NCT06882356 - The Glaucoma and Retinopathy Screening Study | Biotech Hunter

Enrollment

2,000

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

September 30, 2030

Study Completion Date

September 30, 2030

Conditions

Glaucoma

Interventions

DEVICE

AI-based glaucoma screening

AI analysis of fundus photographs to detect signs of glaucoma, added to AI-based diabetic eye disease screening performed for routine clinical care

DEVICE

IOP measurement

Intraocular pressure measurement by Icare tonometer

DEVICE

Virtual Reality Visual Field Testing

Virtual Reality Visual Field Testing by the Olleyes device for participants suspected of having glaucoma

Trial Locations (5)

RECRUITING

Brigham and Women's Primary Care Associates of Longwood, Boston

RECRUITING

MGH Chelsea HealthCare Center, Chelsea

RECRUITING

NSPG Lynn, Lynn

NOT_YET_RECRUITING

NSPG Salem, Salem

RECRUITING

NSPG Saugus, Saugus

All Listed Sponsors

collaborator

Centers for Disease Control and Prevention

FED

lead

Massachusetts Eye and Ear Infirmary

OTHER